BTS clinical statement on aspiration pneumonia
Abstract
Microaspiration, swallowing difficulties and AP are all common, although high-quality, validated estimates of prevalence at population level are lacking.summary of clinical practice points continued (within 3 days of presentation with swallowing difficulties) improves nutritional status and outcomes.Attempts to improve swallow, with a view to restoring eating and discontinuing nasogastric feeding, must be continued.⇒ Percutaneous endoscopic gastrostomy (PEG) should be considered when abnormal swallow presents a continuing high risk of AP and when nasogastric tubes are either poorly tolerated or fail to provide adequate nutrition.⇒ PEG tubes should not always be considered permanent.If safe swallow returns PEG tubes can be removed.⇒ In Chinese and Japanese patients at risk of AP after stroke, and in the absence of contraindications, angiotensinconverting enzyme (ACE) inhibitors should be prescribed to reduce the risk of AP.Insufficient evidence currently exists to support this practice in other ethnic groups. diagnosis of ap⇒ A careful history is key to increasing the likelihood of an accurate diagnosis of AP.In patients presenting with suspected community-acquired pneumonia (CAP), risk factors and features of the history suggestive of aspiration, should be covered.⇒ Chest X-ray fails to detect AP in up to 25% of cases, when compared with thoracic CT scans.⇒ Older patients may have a blunted systemic inflammatory response compared with younger patients. management of ap⇒ For…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.